PTC Therapeutics (PTCT) Free Cash Flow (2017 - 2026)
PTC Therapeutics (PTCT) free cash flow from Jun 30, 2017 to Mar 31, 2026. The TTM PTC Therapeutics (PTCT) free cash flow is -$226M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
PTC Therapeutics (PTCT) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -11.07% |
| 5 Years TTM | -0.34% |
| All Time TTM | +28.04% |
Annual Free Cash Flow change of PTC Therapeutics (PTCT)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$60M | -108.58% |
| 2025 | $702M | -715.06% |
| 2024 | -$114M | -38.89% |
| 2023 | -$187M | -51.92% |
| 2022 | -$389M | +39.04% |
| 2021 | -$280M | +31.91% |
| 2020 | -$212M | +88.53% |
| 2019 | -$112M | +223.55% |
| 2018 | -$35M | +163.98% |
| 2017 | -$13M | -87.51% |
| 2016 | -$105M | N/A |
Comparison PTC Therapeutics (PTCT) five years free cash flow CAGR with competitors
PTC Therapeutics (PTCT) five years free cash flow CAGR is -0.34%.